Unsupported Browser
The American College of Surgeons website is not compatible with Internet Explorer 11, IE 11. For the best experience please update your browser.
Menu
Become a member and receive career-enhancing benefits

Our top priority is providing value to members. Your Member Services team is here to ensure you maximize your ACS member benefits, participate in College activities, and engage with your ACS colleagues. It's all here.

Become a Member
Become a member and receive career-enhancing benefits

Our top priority is providing value to members. Your Member Services team is here to ensure you maximize your ACS member benefits, participate in College activities, and engage with your ACS colleagues. It's all here.

Become a Member
ACS
SESAP 19

About SESAP 19 and SESAP 19 Advanced CME

SESAP 19

Continuing Medical Education Credit Information

Accreditation

The American College of Surgeons is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™

The American College of Surgeons designates this enduring activity for a maximum of 160 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Of the AMA PRA Category 1 Credits™ listed above, a maximum of 160 credits meet the requirements for Self-Assessment.

SESAP 19 Advanced

Continuing Medical Education Credit Information

Accreditation

The American College of Surgeons is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™

The American College of Surgeons designates this enduring activity for a maximum of 104 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Of the AMA PRA Category 1 Credits™ listed above, a maximum of 104 credits meet the requirements for Self-Assessment.

All continuing medical Education (CME) credit for SESAP® 19 and SESAP 19 Advanced must be claimed by October 1, 2028. SESAP 19 and SESAP 19 Advanced will be available online until November 10, 2028, when the edition will be retired.

Requirements to Earn AMA PRA Module 1 Credits™

SESAP 19 includes 640 questions across 9 online modules, all of which must be completed to earn the maximum of 160 CME credits. Individuals who subscribe by selected modules can earn CME credit only for those modules. Credits assigned to each module are as follows:

SESAP 19 Module Number of Credits
Abdomen 21
Alimentary Tract 21
Breast 13
Emergency General Surgery 20
Endocrine 13
Legal, Ethics, Quality, and Safety 6
Perioperative Care 31
Surgical Critical Care 16
Trauma 19
SESAP 19 Module Number of Credits
Abdomen 21
Alimentary Tract 21
Breast 13
Emergency General Surgery 20
Endocrine 13
Legal, Ethics, Quality, and Safety 6
Perioperative Care 31
Surgical Critical Care 16
Trauma 19

SESAP 19 Advanced includes 310 questions across 6 modules, all of which must be completed to earn the maximum of 104 CME credits. Individuals who subscribe by selected modules can earn CME credit only for those modules. Credits assigned to each module are as follows:

SESAP 19 Advanced Module Number of Credits
Advanced Abdomen and Alimentary Tract 25
Advanced Breast 15
Advanced Endocrine 15
Advanced Melanoma, Skin, Sarcoma 15
Advanced Surgical Critical Care 17
Advanced Trauma and Emergency General Surgery 17
SESAP 19 Advanced Module Number of Credits
Advanced Abdomen and Alimentary Tract 25
Advanced Breast 15
Advanced Endocrine 15
Advanced Melanoma, Skin, Sarcoma 15
Advanced Surgical Critical Care 17
Advanced Trauma and Emergency General Surgery 17

For SESAP 19 and SESAP 19 Advanced, participants enrolled for CME credit will be asked to read each question, select an answer, and review the corresponding critique and preferred answer. Participants will test their mastery of the content just learned by answering the same questions in a scrambled fashion and must achieve a score of 80%. If the score is less than 80%, the participant will be asked to review only the incorrect questions and answer those questions again until a score of 80% is achieved. If a score of 80% correct is not achieved after the third attempt, the participant will be asked to start the section over again.

If a module has multiple parts, each part must be completed with a score of 80% to claim credit for the entire module. After achieving a score of 80% for each module, participants will be asked to complete an evaluation form and submit data to the ACS using the internet. Upon successful submission, a CME certificate will be available to print. SESAP 19 and SESAP 19 Advanced are certified for credit through October 1, 2028.

CME

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program.

Diplomates of the American Board of Surgery

By participating in an ACS-accredited activity, you may choose to participate in the automatic transfer of your CME credits to the ABS via the ACCME if you are a Diplomate of the American Board of Surgery (ABS). This is a free service.

Opt In to Automatically Send your CME Data to the ABS

The direct automatic transfer applies to all learners who have an ACS profile, are Diplomates of the ABS, and have provided their ABS ID and date of birth in the ACS MyCME Portal on the Board Certification page.

Step-by-Step Instructions to Access MyCME and Opt in to Transmit Your CME Data:

  1. Log in to your MyCME Portal
  2. Select the Board Certification tab
  3. Enter the American Board of Surgery
  4. Enter your ABS ID
  5. Enter your Day and Month of birth
  6. Next go to the Send CME Data tab
  7. Toggle to Opt In (green) “Yes! I choose to opt in and permit the ACS to automatically transfer all my ACS-accredited CME data to my chosen specialty board earned March 1, 2021, and forward.” 

Please note if you have previously successfully transmitted your ACS-accredited CME credits to the ABS via ACCME, then you can skip steps 2-6, and go directly to the Send CME Data tab, and Toggle to Opt In (green).

Once you have opted to automatically transfer your CME credits to the ABS, please allow 24 hours for the credit to appear in your ABS CME Repository.

You may opt out at any time.

For more information or to request assistance, contact mycme@facs.org

Program Objectives

SESAP 19 is intended for general surgeons. Upon completion of SESAP 19, participants should be able to:

  • Compare their cognitive knowledge at the beginning of the program with evidence-based surgical content for self-assessment and guided learning.
  • Achieve and demonstrate mastery of surgical content to reach predetermined standards in each module, such as those required for ACS Education Credits of Excellence.
  • Pursue lifelong excellence in surgery.
  • Apply newly acquired knowledge to surgical practice.
  • Keep current with surgical advances.

SESAP 19 Advanced is intended for surgeons seeking in-depth knowledge in selected areas. Upon completion of SESAP 19 Advanced, participants should be able to:

  • Assess their initial knowledge of surgical content in selected topics that may be complex, ambiguous, and evolving.
  • Exhibit mastery of advanced surgical content to achieve required criteria in each module, such as those required for ACS Education Credits of Excellence.
  • Exemplify lifelong excellence in surgery.
  • Improve their surgical practice through the application of evidence-based knowledge.
  • Stay current with emerging and complex surgical advances.

Disclosure Information

In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”) held in the last 24 months (see below for definitions). Please note that first authors were required to collect and submit disclosure information on behalf all other authors/contributors, if applicable.

  • Ineligible Company: The ACCME defines an “ineligible company” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.
  • Financial Relationships: Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options, or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. 
  • Conflict of Interest: Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he/she has a financial relationship.

The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.

All relevant financial relationships have been mitigated.

SESAP 19 and SESAP 19 Advanced Planning Committee 

  • Lorrie A. Langdale, MD, FACS, MAMSE (no relevant financial relationship(s) with ineligible companies to disclose)
  • Lena M. Napolitano, MD, FACS, FCCP, MCCM, MAMSE (no relevant financial relationship(s) with ineligible companies to disclose)
  • Tawnya L. Bowles, MD, FACS (no relevant financial relationship(s) with ineligible companies to disclose)
  • Karen Brasel, MD, MPH, FACS, MAMSE (no relevant financial relationship(s) with ineligible companies to disclose)
  • David A. Bull, MD, FACS (no relevant financial relationship(s) with ineligible companies to disclose)
  • Dan Eisenberg, MD, MS, FACS, FASMBS (no relevant financial relationship(s) with ineligible companies to disclose)
  • Dina M. Elaraj, MD, FACS (no relevant financial relationship(s) with ineligible companies to disclose)
  • David A. Gerber, MD, FACS, FAASLD (no relevant financial relationship(s) with ineligible companies to disclose)
  • Richard P.M. Koehler, MD, FACS (no relevant financial relationship(s) with ineligible companies to disclose)
  • Mary R. Kwaan, MD, MPH, FACS (no relevant financial relationship(s) with ineligible companies to disclose)
  • Sean J. Langenfeld, MD, FACS, FASCRS (no relevant financial relationship(s) with ineligible companies to disclose)
  • Linda L. Maerz, MD, FACS, FCCM (no relevant financial relationship(s) with ineligible companies to disclose)
  • Leigh A. Neumayer, MD, MS, MBA, FACS, DABS, MAMSE (no relevant financial relationship(s) with ineligible companies to disclose)
  • John T. Paige MD, FACS, MAMSE (Co-editor—Oxford University Press; Co-editor—Springer Nature; Co-investigator—Avita Medical; Principal investigator—IAMSE; Co-investigator—LSU LIFT; Consultant—Boston Scientific)
  • Jennifer Tseng, MD, FACS (Primary investigator—Intuitive Surgical; Training course participant—Stryker; Training course participant—Elucent)
  • John T. Vetto, MD, FACS, FSSO, FAACE (Speaker—Castle Biosciences)
  • Tracy S. Wang, MD, MPH, FACS, (no relevant financial relationship(s) with ineligible companies to disclose)
  • Travis P. Webb, MD, MHPE, FACS, MAMSE (no relevant financial relationship(s) with ineligible companies to disclose)
  • John A. Weigelt, MD, DVM, FACS, MAMSE (no relevant financial relationship(s) with ineligible companies to disclose)
  • Catherine M. Wittgen, MD, FACS (Adjudication committee chair—CVRX; Consultant—Organogenesis)

SESAP 19 and SESAP 19 Advanced Authors

  • Dalliah M. Black, MD, FACS (no relevant financial relationship(s) with ineligible companies to disclose)
  • Tawnya L. Bowles, MD, FACS (no relevant financial relationship(s) with ineligible companies to disclose)
  • Karen Brasel, MD, MPH, FACS, MAMSE (no relevant financial relationship(s) with ineligible companies to disclose)
  • David A. Bull, MD, FACS (no relevant financial relationship(s) with ineligible companies to disclose)
  • Erin E. Burke, MD, MS, FACS (no relevant financial relationship(s) with ineligible companies to disclose)
  • Casey M. Calkins, MD, FACS, FAAP (no relevant financial relationship(s) with ineligible companies to disclose)
  • Jaclyn Clark, MD, MSHPE, FACS (no relevant financial relationship(s) with ineligible companies to disclose)
  • Kathryn Coan, MD, MBA, FACS (no relevant financial relationship(s) with ineligible companies to disclose)
  • Elizabeth Dauer, MD, FACS (no relevant financial relationship(s) with ineligible companies to disclose)
  • E. Patchen Dellinger, MD, FACS (Consultant— GST Micro; Consultant— Ferring Pharmaceuticals)
  • Jay J. Doucet, MD, MSc, FACS, FRCSC, RDMS (no relevant financial relationship(s) with ineligible companies to disclose)
  • Casey B. Duncan, MD, MS, FACS, FSSO (no relevant financial relationship(s) with ineligible companies to disclose)
  • Anne P. Ehlers, MD, MPH, FACS (no relevant financial relationship(s) with ineligible companies to disclose)
  • Dan Eisenberg, MD, MS, FACS, FASMBS (no relevant financial relationship(s) with ineligible companies to disclose)
  • Dina M. Elaraj, MD, FACS (no relevant financial relationship(s) with ineligible companies to disclose)
  • David A. Gerber, MD, FACS, FAASLD (no relevant financial relationship(s) with ineligible companies to disclose)
  • Sarah L.M. Greenberg, MD, MPH, FACS, FAAP (no relevant financial relationship(s) with ineligible companies to disclose)
  • Jenny Guido, MD, FACS (no relevant financial relationship(s) with ineligible companies to disclose)
  • Ivy N. Haskins, MD, FACS, FASMBS, DABOM (no relevant financial relationship(s) with ineligible companies to disclose)
  • William Hope, MD, FACS (no relevant financial relationship(s) with ineligible companies to disclose)
  • Nathalie Johnson, MD, FACS, DHL (no relevant financial relationship(s) with ineligible companies to disclose)
  • Kyle J. Kalkwarf, MD, FACS (no relevant financial relationship(s) with ineligible companies to disclose)
  • Andrew Kastenmeier, MD, FACS (Teacher and Speaker, Gore Medical—Honorarium)
  • Uzer Khan, MD, MBBS, FACS (no relevant financial relationship(s) with ineligible companies to disclose)
  • Richard P.M. Koehler, MD, FACS (no relevant financial relationship(s) with ineligible companies to disclose)
  • Lindsay E.Y. Kuo, MD, MBA, FACS (no relevant financial relationship(s) with ineligible companies to disclose)
  • Mary R. Kwaan, MD, FACS (no relevant financial relationship(s) with ineligible companies to disclose)
  • Lorrie A. Langdale, MD, FACS, MAMSE (no relevant financial relationship(s) with ineligible companies to disclose)
  • Sean J. Langenfeld, MD, FACS, FASCRS (no relevant financial relationship(s) with ineligible companies to disclose)
  • Robert B. Lim, MD, FACS, FASMBS (Consultant—UpToDate)
  • Dana Lin, MD, FACS (no relevant financial relationship(s) with ineligible companies to disclose)
  • Linda L. Maerz, MD, FACS, FCCM (no relevant financial relationship(s) with ineligible companies to disclose)
  • Grace Z. Mak, MD, FACS (no relevant financial relationship(s) with ineligible companies to disclose)
  • Samuel P. Mandell, MD, MPH, FACS, FABA (no relevant financial relationship(s) with ineligible companies to disclose)
  • Erin C. Maynard, MD, FACS (no relevant financial relationship(s) with ineligible companies to disclose)
  • David E. Meyer, MD, MS, FACS (no relevant financial relationship(s) with ineligible companies to disclose)
  • Harveshp Mogal, MD, MS, FACS (no relevant financial relationship(s) with ineligible companies to disclose)
  • Rachel S. Morris, MD, FACS (no relevant financial relationship(s) with ineligible companies to disclose)
  • Lena M. Napolitano, MD, FACS, FCCP, MCCM, MAMSE (no relevant financial relationship(s) with ineligible companies to disclose)
  • Leigh Neumayer, MD, MS, MBA, FACS, DABS, MAMSE (no relevant financial relationship(s) with ineligible companies to disclose)
  • Vahagn C. Nikolian, MD, FACS (Consultant—Caresynthax; Consultant—Medtronic; Consultant—Intuitive Surgical)
  • John T. Paige, MD, FACS, MAMSE (Co-editor—Oxford University Press; Co-editor—Springer Nature; Co-investigator—Avita Medical; Principal investigator—IAMSE; Co-investigator—LSU LIFT; Consultant—Boston Scientific)
  • Sharla Gayle Patterson, MD, MBA, FACS (Speaker—American Society of Breast Surgeons)
  • Jennifer E. Rosen, MD, FACS (Speaker—Corcept)
  • Sabrina E. Sanchez, MD, MPH, FACS (no relevant financial relationship(s) with ineligible companies to disclose)
  • Tamara E. Saunders, MD, FACS (no relevant financial relationship(s) with ineligible companies to disclose)
  • Paul J. Schenarts, MD, FACS, MAMSE (no relevant financial relationship(s) with ineligible companies to disclose)
  • Maria Sfakianos, MD, FACS (no relevant financial relationship(s) with ineligible companies to disclose)
  • Lance E. Stuke, MD, MPH, FACS (no relevant financial relationship(s) with ineligible companies to disclose)
  • Jennifer Tseng, MD, FACS (Primary investigator—Intuitive Surgical; Training course participant—Stryker; Training course participant—Elucent)
  • John T. Vetto, MD, FACS, FSSO, FAACE (Speaker—Castle Biosciences)
  • Tracy S. Wang, MD, MPH, FACS (no relevant financial relationship(s) with ineligible companies to disclose)
  • Travis P. Webb, MD, MHPE, FACS, MAMSE (no relevant financial relationship(s) with ineligible companies to disclose)
  • Cassandra Q. White, MD, FACS (no relevant financial relationship(s) with ineligible companies to disclose)
  • Catherine M. Wittgen, MD, FACS (Adjudication committee chair—CVRX; Consultant—Organogenesis)
  • Robert B. Yates, MD, FACS (no relevant financial relationship(s) with ineligible companies to disclose)
  • Nicole Zern, MD, FACS (no relevant financial relationship(s) with ineligible companies to disclose)

Consultants

  • Ajit K. Sachdeva, MD, FACS, FRCSC, FSACME, MAMSE (no relevant financial relationship(s) with ineligible companies to disclose)
  • Patrice Gabler Blair, DrPH, MPH (no relevant financial relationship(s) with ineligible companies to disclose)

Staff

  • Julia C. Dudek, MPH (no relevant financial relationship(s) with ineligible companies to disclose)
  • Chrysa M. Cullather, MS (no relevant financial relationship(s) with ineligible companies to disclose)
  • Katherine M. Greenock, MS (no relevant financial relationship(s) with ineligible companies to disclose)
  • Gracie M. Martin (no relevant financial relationship(s) with ineligible companies to disclose)

Education Credits of Excellence

Surgeons interested in achieving higher levels of cognitive skills have the opportunity to earn Education Credits of Excellence offered by the ACS Division of Education and approved by the ACS Board of Regents. For each module, participants have an option for additional study to demonstrate a higher level of expertise in the content area. The Education Credits of Excellence are entirely optional and are designed to encourage further learning and challenge surgeons who want to pursue a higher level of achievement.

Royal College of Physicians and Surgeons of Canada Accreditation

Through an agreement between the American College of Surgeons and the Royal College of Physicians and Surgeons of Canada, MOC Program participants may record completed self-assessment programs or simulation activities developed and accredited by the American College of Surgeons in Section 3 of the Royal College’s MOC Program.

SESAP 19 and SESAP 19 Advanced CME credit must be claimed by December 31, 2025, to be reported under Section 3 of the Royal College’s MOC Program.